Company profile
UK company 08027459, incorporated on 12 April 2012.
Home Page - Aptamer Group
Rapid Optimer development as antibody alternatives for therapeutic, drug delivery, diagnostics and bioprocessing.
Company number 08027459
Updated 07 Jul 2026 09:49
Financial period: 1 Jul 2024 to 30 Jun 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
I am adding this here because Dr David Bunka one of the founders of this company trained with me as a postgraduate and a post-doctoral fellow in robotic aptamer selection. Subsequently with his co-founder, Dr Aaron Tolley, who trained with my former post-doctoral fellow, Prof Nicola Stonehouse, they founded Aptamer Solutions a start-up based on the science park in York. Their company which has supplied aptamers largely to the UK marketplace just had its first public offering a few months ago. None of this would have been possible without the training opportunities offered by these grants.
See above, this is now a listed company.
